Biomarkers in Dermal Interstitial Fluid for Early Diagnosis and Follow-up of Cardiovascular Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-08

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sampling of dISF and blood plasma for qualitative measurements.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

NCT00415948

Acute Coronary Syndrome (ACS)

COMPLETED

Left Ventricular Structural Predictors of Sudden Cardiac Death

NCT01076660

Ischemic Cardiomyopathy Nonischemic Cardiomyopathy

RECRUITING

Circulating Markers for Ischemic Heart Disease

NCT00762333

Myocardial Infarction Ischemia Congestive Heart Failure

RECRUITING

Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

NCT06688396

Dilated Cardiomyopathy Heart Failure Heart Disease

RECRUITING NA

Biomarkers in Acute Cardiac Care

NCT02355457

Acute Coronary Syndrome Myocardial Infarction Chest Pain

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sampling of dISF will be performed to investigate biomarkers in dISF for early diagnosis and follow-up of cardiovascular diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Cardiovascular diseases

No interventions assigned to this group

Group 2

Reference

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Group 1: Chronic heart failure with stable therapy. NYHA classification II, III and IV. Age \> 60 years. Group 2: Age 18-40 years.

Exclusion Criteria

* Participating in another clinical investigation which may affect the study outcome according to clinical judgement.
* Previous use of sampling system used.
* Pregnancy or lactating.
* Any disease or condition that may be affected.
* Individuals who lack the ability to fully consent to participate in the study.
* Severe skin injury.
* Tattoo or piercing close to sampling area.
* Group 1: All forms of emergency care.
* Group 1: Non-stable therapy.
* Group 1: Sepsis.
* Group 1: BMI \> 30kg/m2.
* Group 1: Age \> 84 years.
* Group 2: Known heart or vascular disease.
* Group 2: Diabetes.
* Group 2: Kidney disease.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No